Key result
Highest quartile of neutrophil-lymphocyte ratio linked to ~76% higher all-cause mortality.
Why the study?
Does an elevated neutrophil-lymphocyte ratio predict all-cause and cardiovascular mortality in patients with diabetes or prediabetes and comorbid obstructive sleep apnea symptoms?
Cohort (n=5,432)
Yes
Does an elevated neutrophil-lymphocyte ratio predict all-cause and cardiovascular mortality in patients with diabetes or prediabetes and comorbid obstructive sleep apnea symptoms?
Answers are grounded in this paper and cite their sources.
Elevated neutrophil-lymphocyte ratio is a significant prognostic indicator for increased all-cause and cardiovascular mortality in patients with diabetes or prediabetes and comorbid OSA symptoms.
Objective: The neutrophil-lymphocyte ratio (NLR) is a hematological marker to assess systemic inflammation and immune status. The relationship between NLR and the risk of mortality in individuals with diabetes mellitus or pre-diabetes mellitus who have comorbid symptoms of obstructive sleep apnea is unknown. Our study aims to evaluate the association between NLR and all-cause and cardiovascular mortality in this population. Methods: Our research enrolled 5432 patients from the National Health and Nutrition Examination Surveys (2005-2008 and 2015-2018) diagnosed with diabetes or prediabetes combined with symptoms of OSA. Mortality outcomes were ascertained by linkage to the National Death Index (NDI) records for December 31, 2019. The association between NLR and mortality was tested using multivariate Cox regression models. The non-linear relationship was analyzed based on restricted cubic spline curves (RCS). Kaplan-Meier (K-M) survival analysis and time-dependent subject operating characteristic curve (ROC) analysis were performed to assess the predictive value of NLR on patient survival. Results: In a median follow-up period of 52 months, study participants experienced 632 deaths from all causes and 143 deaths due to cardiovascular disease. According to Cox regression analysis, the fourth quartile was associated with higher all-cause mortality (HR=1.76, 95% CI 1.25-2.49) and cardiovascular mortality (HR=3.08, 95% CI 1.54-6.18) compared with the first quartile under the fully adjusted model. Meanwhile, K-M survival curves showed that all-cause and cardiovascular mortality increased with increasing NLR levels, with the highest mortality in the fourth quartile group. In addition, the areas under the curve (AUC) of the 3, 5and 10year survival were 0.67, 0.63, and 0.74 for all-cause mortality, respectively. Meanwhile, the AUC values for cardiovascular mortality were 0.73, 0.56, and 0.69. Conclusion: For individuals with diabetes and OSA symptoms, elevated NLR can serve as a prognostic indicator for all-cause and cardiovascular mortality.
No takes yet. Share an insight, caveat, or question.
He et al. (2025) conducted a cohort in Diabetes or prediabetes with comorbid obstructive sleep apnea symptoms (n=5,432). Elevated neutrophil-lymphocyte ratio (NLR) vs. Lowest quartile of NLR was evaluated on All-cause mortality (HR 1.76, 95% CI 1.25-2.49). The highest quartile of neutrophil-lymphocyte ratio was associated with increased all-cause mortality compared to the lowest quartile (HR 1.76; 95% CI 1.25-2.49).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: